These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31414991)

  • 21. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis.
    Edwin TH; Strand BH; Persson K; Engedal K; Selbæk G; Knapskog AB
    Int Psychogeriatr; 2021 Aug; 33(8):779-789. PubMed ID: 33213607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Scarabino D; Broggio E; Gambina G; Corbo RM
    Exp Gerontol; 2017 Nov; 98():143-147. PubMed ID: 28827085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis of amnestic mild cognitive impairment: clinical and immunological correlations].
    Ponomareva EV; Krinsky SA; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):16-22. PubMed ID: 34870909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of the Clinical Dementia Rating Scale Sum of Boxes Scores in Detecting and Staging Cognitive Impairment/Dementia in Brazilian Patients With Low Educational Attainment.
    Lima APV; Castilhos R; Chaves MLF
    Alzheimer Dis Assoc Disord; 2017; 31(4):322-327. PubMed ID: 28700383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.
    Mouchet J; Betts KA; Georgieva MV; Ionescu-Ittu R; Butler LM; Teitsma X; Delmar P; Kulalert T; Zhu J; Lema N; Desai U
    J Alzheimers Dis; 2021; 82(4):1667-1682. PubMed ID: 34219723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer's disease.
    Pillai JA; Bena J; Bebek G; Bekris LM; Bonner-Jackson A; Kou L; Pai A; Sørensen L; Neilsen M; Rao SM; Chance M; Lamb BT; Leverenz JB;
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1225-1239. PubMed ID: 32634865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    Scheltens NME; Tijms BM; Heymans MW; Rabinovici GD; Cohn-Sheehy BI; Miller BL; Kramer JH; Wolfsgruber S; Wagner M; Kornhuber J; Peters O; Scheltens P; van der Flier WM;
    J Alzheimers Dis; 2018; 65(3):1029-1039. PubMed ID: 30103316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
    Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
    Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin, hsCRP, TNF-α and IL-6 levels from normal aging to dementia: Relationship with cognitive and functional status.
    Magalhães CA; Ferreira CN; Loures CMG; Fraga VG; Chaves AC; Oliveira ACR; de Souza LC; Resende EPF; Carmona KC; Guimarães HC; Cintra MTG; Lanna IN; Zauli DAG; Bicalho MA; Carvalho MG; Sousa LP; Caramelli P; Gomes KB
    J Clin Neurosci; 2018 Oct; 56():150-155. PubMed ID: 30150062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease progression modeling of Alzheimer's disease according to education level.
    Kim KW; Woo SY; Kim S; Jang H; Kim Y; Cho SH; Kim SE; Kim SJ; Shin BS; Kim HJ; Na DL; Seo SW
    Sci Rep; 2020 Oct; 10(1):16808. PubMed ID: 33033321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.
    Bleckwenn M; Kleineidam L; Wagner M; Jessen F; Weyerer S; Werle J; Wiese B; Lühmann D; Posselt T; König HH; Brettschneider C; Mösch E; Weeg D; Fuchs A; Pentzek M; Luck T; Riedel-Heller SG; Maier W; Scherer M
    Br J Gen Pract; 2017 Feb; 67(655):e111-e117. PubMed ID: 27993897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
    Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
    Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.